| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hypoalphalipoproteinemias | D052456 | 5 associated lipids |
| Atherosclerosis | D050197 | 85 associated lipids |
| Death, Sudden, Cardiac | D016757 | 12 associated lipids |
| Thrombosis | D013927 | 49 associated lipids |
| Renal Artery Obstruction | D012078 | 8 associated lipids |
| Polycythemia Vera | D011087 | 13 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Hyperlipidemias | D006949 | 73 associated lipids |
| Hypercholesterolemia | D006937 | 91 associated lipids |
| Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
| Diabetes Mellitus, Type 1 | D003922 | 56 associated lipids |
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Cerebrovascular Disorders | D002561 | 25 associated lipids |
| Brain Ischemia | D002545 | 89 associated lipids |
| Cerebral Hemorrhage | D002543 | 13 associated lipids |
| Cardiovascular Diseases | D002318 | 24 associated lipids |
| Blood Platelet Disorders | D001791 | 12 associated lipids |
| Atrial Fibrillation | D001281 | 16 associated lipids |
| Asthma | D001249 | 52 associated lipids |
| Albuminuria | D000419 | 18 associated lipids |
11-dehydro-txb2
Cross Reference
Introduction
To understand associated biological information of 11-dehydro-txb2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 11-dehydro-txb2?
11-dehydro-txb2 is suspected in Risk factor, cardiovascular, Acute coronary syndrome, thrombocytosis, Chronic ischemic heart disease NOS, Diabetes Mellitus, Diabetes Mellitus, Non-Insulin-Dependent and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 11-dehydro-txb2
PubChem Associated disorders and diseases
What pathways are associated with 11-dehydro-txb2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 11-dehydro-txb2?
There are no associated biomedical information in the current reference collection.
What functions are associated with 11-dehydro-txb2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with 11-dehydro-txb2?
There are no associated biomedical information in the current reference collection.
What genes are associated with 11-dehydro-txb2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with 11-dehydro-txb2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with 11-dehydro-txb2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Ikonomidis I et al. | Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment. | 2005 | Am. Heart J. | pmid:15894964 |
| Coppola A et al. | Reduced in vivo oxidative stress following 5-methyltetrahydrofolate supplementation in patients with early-onset thrombosis and 677TT methylenetetrahydrofolate reductase genotype. | 2005 | Br. J. Haematol. | pmid:16173969 |
| Haubelt H et al. | Can platelet function tests predict the clinical efficacy of aspirin? | 2005 | Semin. Thromb. Hemost. | pmid:16149017 |
| Davì G et al. | Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation. | 2005 | Arterioscler. Thromb. Vasc. Biol. | pmid:15472127 |
| Saloheimo P et al. | Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage. | 2005 | Thromb. Res. | pmid:15733969 |
| De Candia E et al. | Abnormal pH-sensing of platelet Na+/H+ exchanger in patients with cardiac syndrome X. | 2005 | Int. J. Cardiol. | pmid:15837078 |
| Sciulli MG et al. | Platelet activation in patients with colorectal cancer. | 2005 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:15626589 |
| Suzuki N et al. | Quantitative liquid chromatography-tandem mass spectrometric analysis of 11-dehydro TXB2 in urine. | 2004 | Prostaglandins Other Lipid Mediat. | pmid:15165035 |
| Hennekens CH et al. | Terms and conditions: semantic complexity and aspirin resistance. | 2004 | Circulation | pmid:15381661 |
| Dippel DW et al. | What is the lowest dose of aspirin for maximum suppression of in vivo thromboxane production after a transient ischemic attack or ischemic stroke? | 2004 | Cerebrovasc. Dis. | pmid:15026612 |